Lazard Capital Analysts Begin Coverage on AthenaHealth (ATHN)
Shares of AthenaHealth traded up 1.32% during mid-day trading on Wednesday, hitting $78.01. AthenaHealth has a 52 week low of $38.97 and a 52 week high of $78.24. The company has a market cap of $2.796 billion and a P/E ratio of 151.56.
AthenaHealth last announced its earnings results on Thursday, April 26th. The company reported $0.17 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.17. AthenaHealth’s revenue was up 38.1% compared to the same quarter last year. On average, analysts predict that AthenaHealth will post $0.27 earnings per share next quarter.
A number of other analysts have also recently weighed in on ATHN. Analysts at Morgan Stanley (NYSE: MS) upgraded shares of AthenaHealth from an “underweight” rating to an “equal weight” rating in a research note to investors on Thursday, May 3rd. Separately, analysts at Auriga reiterated a “sell” rating on shares of AthenaHealth in a research note to investors on Monday, April 30th. Finally, analysts at Piper Jaffray (NYSE: PJC) raised their price target on shares of AthenaHealth from $70.00 to $80.00 in a research note to investors on Sunday, April 29th. They now have an “overweight” rating on the stock.
athenahealth, Inc. (athenahealth) is a business services company that provides ongoing billing, clinical-related, and other related services to its customers.